PI suspect the unsw research funded by bill may have more...

P
I suspect the unsw research funded by bill may have more relevance to avx than that

as described, it is about investigating reduced doses per individual to allow a greater number of individuals to be treated

this may be particularly relevant with 3tc, ftc and others going off patent

but going off patent, with lower control and lower dose per treatment, is only going to lead to more resistance...

unless combined with something to reduce/treat that resistance...

atc